(CHRW) CH Robinson Worldwide - Ratings and Ratios
Freight, Logistics, Brokerage, Produce, Forwarding
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.3% |
| Value at Risk 5%th | 39.6% |
| Relative Tail Risk | -14.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 32.59 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.633 |
| Beta Downside | 0.799 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.50% |
| Mean DD | 11.09% |
| Median DD | 9.88% |
Description: CHRW CH Robinson Worldwide October 30, 2025
C.H. Robinson Worldwide Inc. (NASDAQ:CHRW) is a global logistics provider that operates two primary segments: North American Surface Transportation and Global Forwarding. The firm brokers truckload, less-than-truckload (LTL), intermodal, air, and ocean freight, while also offering customs brokerage, managed-service warehousing, and door-to-door solutions.
Beyond traditional freight brokerage, CHRW runs the Robinson Fresh business, sourcing and distributing fresh produce to grocery chains, restaurants, and food-service distributors through a network of independent growers. This vertical adds a perishable-goods revenue stream that is relatively insulated from macro-economic cycles.
Key operational metrics from recent filings show FY 2023 revenue of roughly $16.5 billion, an adjusted EBITDA margin near 7 %, and a 5 % year-over-year increase in intermodal volume-a segment that benefits from rail capacity constraints and higher rail-to-truck rate differentials. The company’s growth is also tied to broader sector drivers such as sustained e-commerce demand, ongoing truck-driver shortages, and volatile freight-rate indexes that can boost brokerage fees.
For a deeper quantitative dive, you might explore ValueRay’s detailed financial model for CHRW.
CHRW Stock Overview
| Market Cap in USD | 18,051m |
| Sub-Industry | Air Freight & Logistics |
| IPO / Inception | 1997-10-15 |
| Return 12m vs S&P 500 | 27.3% |
| Analyst Rating | 3.81 of 5 |
CHRW Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.05% |
| Yield on Cost 5y | 3.81% |
| Yield CAGR 5y | 4.79% |
| Payout Consistency | 100.0% |
| Payout Ratio | 49.7% |
CHRW Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 19.03% |
| CAGR/Max DD Calmar Ratio | 0.57 |
| CAGR/Mean DD Pain Ratio | 1.72 |
| Current Volume | 1570.1k |
| Average Volume | 1546.8k |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (600.1m TTM) > 0 and > 6% of Revenue (6% = 990.3m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 12.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.68% (prev 6.18%; Δ 0.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 877.0m > Net Income 600.1m (YES >=105%, WARN >=100%) |
| Net Debt (1.37b) to EBITDA (977.0m) ratio: 1.40 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (121.4m) change vs 12m ago 0.19% (target <= -2.0% for YES) |
| Gross Margin 8.30% (prev 6.95%; Δ 1.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 304.5% (prev 316.4%; Δ -11.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.97 (EBITDA TTM 977.0m / Interest Expense TTM 146.7m) >= 6 (WARN >= 3) |
Altman Z'' 8.07
| (A) 0.21 = (Total Current Assets 2.99b - Total Current Liabilities 1.88b) / Total Assets 5.23b |
| (B) 1.15 = Retained Earnings (Balance) 6.01b / Total Assets 5.23b |
| warn (B) unusual magnitude: 1.15 — check mapping/units |
| (C) 0.16 = EBIT TTM 876.3m / Avg Total Assets 5.42b |
| (D) 1.76 = Book Value of Equity 5.95b / Total Liabilities 3.37b |
| Total Rating: 8.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.58
| 1. Piotroski 4.50pt |
| 2. FCF Yield 4.42% |
| 3. FCF Margin 5.20% |
| 4. Debt/Equity 0.81 |
| 5. Debt/Ebitda 1.40 |
| 6. ROIC - WACC (= 14.35)% |
| 7. RoE 33.82% |
| 8. Rev. Trend -73.72% |
| 9. EPS Trend 55.58% |
What is the price of CHRW shares?
Over the past week, the price has changed by -0.73%, over one month by +18.24%, over three months by +24.12% and over the past year by +43.08%.
Is CHRW a buy, sell or hold?
- Strong Buy: 11
- Buy: 2
- Hold: 11
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the CHRW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 152.2 | 0.3% |
| Analysts Target Price | 152.2 | 0.3% |
| ValueRay Target Price | 171 | 12.7% |
CHRW Fundamental Data Overview November 17, 2025
P/E Trailing = 30.9939
P/E Forward = 26.455
P/S = 1.0937
P/B = 9.7192
P/EG = 2.1508
Beta = 0.909
Revenue TTM = 16.50b USD
EBIT TTM = 876.3m USD
EBITDA TTM = 977.0m USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 72.2m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.37b USD (from netDebt column, last quarter)
Enterprise Value = 19.42b USD (18.05b + Debt 1.50b - CCE 136.8m)
Interest Coverage Ratio = 5.97 (Ebit TTM 876.3m / Interest Expense TTM 146.7m)
FCF Yield = 4.42% (FCF TTM 857.7m / Enterprise Value 19.42b)
FCF Margin = 5.20% (FCF TTM 857.7m / Revenue TTM 16.50b)
Net Margin = 3.64% (Net Income TTM 600.1m / Revenue TTM 16.50b)
Gross Margin = 8.30% ((Revenue TTM 16.50b - Cost of Revenue TTM 15.14b) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev 8.65%)
Tobins Q-Ratio = 3.71 (Enterprise Value 19.42b / Total Assets 5.23b)
Interest Expense / Debt = 6.29% (Interest Expense 94.5m / Debt 1.50b)
Taxrate = 20.58% (42.2m / 205.2m)
NOPAT = 695.9m (EBIT 876.3m * (1 - 20.58%))
Current Ratio = 1.59 (Total Current Assets 2.99b / Total Current Liabilities 1.88b)
Debt / Equity = 0.81 (Debt 1.50b / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 1.40 (Net Debt 1.37b / EBITDA 977.0m)
Debt / FCF = 1.59 (Net Debt 1.37b / FCF TTM 857.7m)
Total Stockholder Equity = 1.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.48% (Net Income 600.1m / Total Assets 5.23b)
RoE = 33.82% (Net Income TTM 600.1m / Total Stockholder Equity 1.77b)
RoCE = 29.63% (EBIT 876.3m / Capital Employed (Equity 1.77b + L.T.Debt 1.18b))
RoIC = 22.44% (NOPAT 695.9m / Invested Capital 3.10b)
WACC = 8.09% (E(18.05b)/V(19.55b) * Re(8.35%) + D(1.50b)/V(19.55b) * Rd(6.29%) * (1-Tc(0.21)))
Discount Rate = 8.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.75%
[DCF Debug] Terminal Value 80.45% ; FCFE base≈599.9m ; Y1≈740.1m ; Y5≈1.26b
Fair Price DCF = 171.3 (DCF Value 20.24b / Shares Outstanding 118.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 55.58 | EPS CAGR: 11.81% | SUE: 0.60 | # QB: 0
Revenue Correlation: -73.72 | Revenue CAGR: -7.11% | SUE: -0.56 | # QB: 0
Additional Sources for CHRW Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle